Computational Protein Design for Next-Generation Cellular Therapeutics
Jan 25, 2021 10:00am ‐ Jan 25, 2021 10:40am
Keynote(s):
- David Baker, PhD, University of Washington
Welcoming Remarks and Keynote Address
Jan 25, 2021 10:00am ‐ Jan 25, 2021 10:40am
Organizer(s):
- Kole T. Roybal, PhD, University of California, San Francisco
Keynote(s):
- David Baker, PhD, University of Washington
Next-Generation CART Approaches Exploiting Natural Killer Receptor Targeting
Jan 25, 2021 10:40am ‐ Jan 25, 2021 11:05am
Speaker(s):
- David E. Gilham, PhD, Celyad
The Current State of Cellular Therapies for Cancer: Lessons from the Clinic
Jan 25, 2021 10:40am ‐ Jan 25, 2021 1:00pm
Co-Chair(s):
- Kole T. Roybal, PhD, University of California, San Francisco
- Yvonne Y. Chen, PhD, University of California, Los Angeles
CAR T Cells for the Treatment of Brain Malignancies
Jan 25, 2021 11:45am ‐ Jan 25, 2021 12:10pm
Speaker(s):
- Christine E. Brown, PhD, Beckman Research Institute, City of Hope
Manufacturing Next-Generation Cellular Therapies
Jan 25, 2021 12:10pm ‐ Jan 25, 2021 12:35pm
Speaker(s):
- Isabelle Riviere, PhD, Memorial Sloan-Kettering Cancer Center
Allogeneic CAR T Therapy for the Treatment of Cancer
Jan 25, 2021 12:35pm ‐ Jan 25, 2021 1:00pm
Speaker(s):
- Barbra Sasu, PhD, Allogene Therapeutics
Career Roundtable
Jan 25, 2021 2:30pm ‐ Jan 25, 2021 3:30pm
Panelist(s):
- Darrell J. Irvine, PhD, Massachusetts Institute of Technology
- Marcela V. Maus, MD, PhD, Harvard Medical School
- Jane L. Grogan, PhD, Arsenal Biosciences